ATE531701T1 - Neue quaternüre ammoniumverbindungen - Google Patents
Neue quaternüre ammoniumverbindungenInfo
- Publication number
- ATE531701T1 ATE531701T1 AT03791398T AT03791398T ATE531701T1 AT E531701 T1 ATE531701 T1 AT E531701T1 AT 03791398 T AT03791398 T AT 03791398T AT 03791398 T AT03791398 T AT 03791398T AT E531701 T1 ATE531701 T1 AT E531701T1
- Authority
- AT
- Austria
- Prior art keywords
- prevention
- treatment
- drugs
- quaternure
- new
- Prior art date
Links
- 150000003868 ammonium compounds Chemical class 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- 230000002265 prevention Effects 0.000 abstract 4
- 206010008635 Cholestasis Diseases 0.000 abstract 2
- 208000004930 Fatty Liver Diseases 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 208000019423 liver disease Diseases 0.000 abstract 2
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 abstract 1
- 208000033222 Biliary cirrhosis primary Diseases 0.000 abstract 1
- 206010008609 Cholangitis sclerosing Diseases 0.000 abstract 1
- 206010019708 Hepatic steatosis Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000012654 Primary biliary cholangitis Diseases 0.000 abstract 1
- 150000007657 benzothiazepines Chemical class 0.000 abstract 1
- 108091022863 bile acid binding Proteins 0.000 abstract 1
- 102000030904 bile acid binding Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000010706 fatty liver disease Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 201000000742 primary sclerosing cholangitis Diseases 0.000 abstract 1
- 208000010157 sclerosing cholangitis Diseases 0.000 abstract 1
- 231100000240 steatosis hepatitis Toxicity 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002248586 | 2002-08-28 | ||
| JP2002364725 | 2002-12-17 | ||
| PCT/JP2003/010980 WO2004020421A1 (ja) | 2002-08-28 | 2003-08-28 | 新規な４級アンモニウム化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE531701T1 true ATE531701T1 (de) | 2011-11-15 |
Family
ID=31980497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03791398T ATE531701T1 (de) | 2002-08-28 | 2003-08-28 | Neue quaternüre ammoniumverbindungen |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1535913B1 (de) |
| JP (1) | JP4497472B2 (de) |
| KR (1) | KR100990524B1 (de) |
| CN (1) | CN100494185C (de) |
| AT (1) | ATE531701T1 (de) |
| AU (1) | AU2003257578B2 (de) |
| CA (1) | CA2497345C (de) |
| WO (1) | WO2004020421A1 (de) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070026392A (ko) * | 2004-02-27 | 2007-03-08 | 아사히 가세이 파마 가부시키가이샤 | 신규 벤조티아제핀 및 벤조티에핀 화합물 |
| FI20055503A0 (fi) * | 2005-09-20 | 2005-09-20 | Fennopharma Oy | Uudet kvaternääriset polymeerit |
| EP2367554A4 (de) * | 2008-11-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von adipositas und diabetes |
| EP3593802A3 (de) | 2010-05-26 | 2020-03-25 | Satiogen Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von diabetes, adipositas und entzündlichen magen-darm-erkrankungen |
| ES2586931T3 (es) | 2010-11-04 | 2016-10-19 | Albireo Ab | Inhibidores de IBAT para el tratamiento de enfermedades hepáticas |
| RU2619215C2 (ru) * | 2010-11-08 | 2017-05-12 | Альбирео Аб | Фармацевтическая комбинация, включающая ibat-ингибитор и связующее желчной кислоты |
| EP2637667A4 (de) * | 2010-11-08 | 2014-06-25 | Albireo Ab | Ibat-hemmer zur behandlung von stoffwechselerkrankungen und verwandten leiden |
| BR112014010223B8 (pt) | 2011-10-28 | 2021-02-23 | Lumena Pharmaceuticals Llc | uso de uma composição compreendendo inibidores de reciclagem de ácido de bílis e forma de dosagem pediátrica |
| KR102051031B1 (ko) * | 2011-10-28 | 2019-12-02 | 루메나 파마수티컬즈, 인코포레이티드 | 고담혈증 및 담즙 정체성 간 질환 치료용 담즙산 재순환 억제제 |
| WO2014071182A1 (en) | 2012-11-01 | 2014-05-08 | Massachusetts Institute Of Technology | Directed evolution of synthetic gene cluster |
| EP2968230A2 (de) * | 2013-03-15 | 2016-01-20 | Lumena Pharmaceuticals, Inc. | Gallensäurerückflusshemmer zur behandlung von primär sklerosierender cholongitis und entzündlichen darmerkrankungen |
| JO3301B1 (ar) | 2013-04-26 | 2018-09-16 | Albireo Ab | تعديلات بلورية على إيلوبيكسيبات |
| CN106659726A (zh) | 2014-06-25 | 2017-05-10 | Ea制药株式会社 | 固体制剂及其着色防止或着色减少方法 |
| EP3012252A1 (de) | 2014-10-24 | 2016-04-27 | Ferring BV | Kristalline Form von elobixibat |
| KR102197507B1 (ko) | 2015-07-13 | 2020-12-31 | 피벗 바이오, 인크. | 식물 형질 개선을 위한 방법 및 조성물 |
| WO2017062412A1 (en) | 2015-10-05 | 2017-04-13 | Massachusetts Institute Of Technology | Nitrogen fixation using refactored nif clusters |
| EP3413878B1 (de) | 2016-02-09 | 2021-04-14 | Albireo AB | Orale cholestyraminformulierungen und verwendung davon |
| EP3413877B1 (de) | 2016-02-09 | 2021-04-07 | Albireo AB | Orale cholestyraminformulierungen und verwendung davon |
| EP3413875B1 (de) | 2016-02-09 | 2020-01-29 | Albireo AB | Cholestyraminpellets und verfahren zur herstellung davon |
| UA129256C2 (uk) | 2017-01-12 | 2025-03-05 | Півот Байо, Інк. | Спосіб ідентифікації штаму мікроорганізму, який продукує азот, небобова рослина, колонізована таким штамом, спосіб збільшення фіксації азоту у небобових рослин та композиція для збільшення фіксації азоту у небобових рослин |
| WO2018195649A1 (en) * | 2017-04-26 | 2018-11-01 | Alberta Research Chemicals Inc. | Substituted tetrahydropyridine derivatives as ido-1 inhibitors and uses thereof |
| CN110996915B (zh) | 2017-08-09 | 2023-10-03 | 阿尔比里奥公司 | 考来烯胺丸粒、口服考来烯胺制剂及其用途 |
| JP2020530448A (ja) | 2017-08-09 | 2020-10-22 | アルビレオ・アクチボラグ | コレスチラミン顆粒、経口コレスチラミン製剤、及びそれらの使用 |
| JP7420712B2 (ja) | 2017-10-25 | 2024-01-23 | ピボット バイオ， インコーポレイテッド | 窒素を固定する操作された微生物を改良するための方法および組成物 |
| US12151988B2 (en) | 2017-10-25 | 2024-11-26 | Pivot Bio, Inc. | Gene targets for nitrogen fixation targeting for improving plant traits |
| JP7391048B2 (ja) | 2018-06-05 | 2023-12-04 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| MX2020013839A (es) | 2018-06-20 | 2021-03-25 | Albireo Ab | Formulacion farmaceutica de odevixibat. |
| EP3813511A4 (de) | 2018-06-27 | 2022-08-03 | Pivot Bio, Inc. | Geführte mikrobielle remodellierung, plattform zur rationellen verbesserung mikrobieller spezies für die landwirtschaft |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| RS63899B1 (sr) | 2019-02-06 | 2023-02-28 | Albireo Ab | Benzotiadiazepinska jedinjenja i njihova upotreba kao modulatora žučnih kiselina |
| TWI835997B (zh) | 2019-02-06 | 2024-03-21 | 瑞典商艾爾比瑞歐公司 | 苯并噻氮呯化合物及其用作膽酸調節劑之用途 |
| WO2020190363A1 (en) | 2019-03-19 | 2020-09-24 | Massachusetts Institute Of Technology | Control of nitrogen fixation in rhizobia that associate with cereals |
| CN114008221A (zh) | 2019-04-25 | 2022-02-01 | 皮沃特生物股份有限公司 | 用于分离和表征由化学诱变产生的泌铵突变体库的高通量方法 |
| CA3158181A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TWI867107B (zh) | 2019-12-04 | 2024-12-21 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯化合物及其作為膽酸調節劑之用途 |
| AR120679A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzoti(di)azepina y su uso como moduladores ácido biliar |
| WO2021110886A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| AR120682A1 (es) | 2019-12-04 | 2022-03-09 | Albireo Ab | Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| EP4069359B1 (de) | 2019-12-04 | 2024-01-03 | Albireo AB | Benzothia(di)azepinverbindungen und ihre verwendung als gallensäuremodulatoren |
| JP7665620B2 (ja) | 2019-12-04 | 2025-04-21 | アルビレオ・アクチボラグ | ベンゾチアジアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| WO2021110887A1 (en) | 2019-12-04 | 2021-06-10 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| BR112022010505A2 (pt) | 2019-12-04 | 2022-09-06 | Albireo Ab | Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar |
| AU2020445067A1 (en) | 2020-05-01 | 2022-12-01 | Pivot Bio, Inc. | Measurement of nitrogen fixation and incorporation |
| WO2022029101A1 (en) | 2020-08-03 | 2022-02-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CA3186857A1 (en) | 2020-08-03 | 2022-02-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| AU2021379076A1 (en) | 2020-11-12 | 2023-06-08 | Albireo Ab | Odevixibat for treating progressive familial intrahepatic cholestasis (pfic) |
| AU2021390172A1 (en) | 2020-12-04 | 2023-06-22 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
| US20230338392A1 (en) | 2022-04-22 | 2023-10-26 | Albireo Ab | Subcutaneous administration of an asbt inhibitor |
| CN119343140A (zh) | 2022-06-09 | 2025-01-21 | 阿尔比里奥公司 | 治疗肝炎 |
| JP2025521736A (ja) | 2022-07-05 | 2025-07-10 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| CN120265290A (zh) | 2022-12-09 | 2025-07-04 | 阿尔比里奥公司 | 治疗肾脏疾病的asbt抑制剂 |
| WO2025146508A1 (en) | 2024-01-05 | 2025-07-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| WO2025146507A1 (en) | 2024-01-05 | 2025-07-10 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL108634A0 (en) * | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
| IL108633A (en) * | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
| US5994391A (en) * | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| NZ331813A (en) * | 1996-03-11 | 2001-03-30 | G | Benzothiepine compounds having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| NZ337830A (en) * | 1997-03-11 | 2001-07-27 | G | Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors |
| GB9821296D0 (en) * | 1998-10-01 | 1998-11-25 | Zeneca Ltd | Composition |
| CA2362147A1 (en) * | 1999-02-12 | 2000-08-17 | Steve A. Kolodziej | 1,2-benzothiazepines for the treatment of hyperlipidemic diseases |
| DE19916108C1 (de) * | 1999-04-09 | 2001-01-11 | Aventis Pharma Gmbh | Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung |
| US20020183307A1 (en) * | 2000-07-26 | 2002-12-05 | Tremont Samuel J. | Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake |
| WO2002053548A1 (fr) * | 2000-12-27 | 2002-07-11 | Banyu Pharmaceutical Co.,Ltd. | Derives de la benzothiazepine |
-
2003
- 2003-08-28 CN CNB038207117A patent/CN100494185C/zh not_active Expired - Fee Related
- 2003-08-28 AU AU2003257578A patent/AU2003257578B2/en not_active Ceased
- 2003-08-28 WO PCT/JP2003/010980 patent/WO2004020421A1/ja not_active Ceased
- 2003-08-28 KR KR1020057003204A patent/KR100990524B1/ko not_active Expired - Fee Related
- 2003-08-28 EP EP03791398A patent/EP1535913B1/de not_active Expired - Lifetime
- 2003-08-28 JP JP2004532766A patent/JP4497472B2/ja not_active Expired - Fee Related
- 2003-08-28 CA CA002497345A patent/CA2497345C/en not_active Expired - Fee Related
- 2003-08-28 AT AT03791398T patent/ATE531701T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| CN1678597A (zh) | 2005-10-05 |
| CN100494185C (zh) | 2009-06-03 |
| CA2497345A1 (en) | 2004-03-11 |
| EP1535913A1 (de) | 2005-06-01 |
| WO2004020421A1 (ja) | 2004-03-11 |
| JP4497472B2 (ja) | 2010-07-07 |
| EP1535913A4 (de) | 2008-04-09 |
| AU2003257578A1 (en) | 2004-03-19 |
| CA2497345C (en) | 2008-10-14 |
| AU2003257578B2 (en) | 2009-01-22 |
| JPWO2004020421A1 (ja) | 2005-12-15 |
| KR20050059088A (ko) | 2005-06-17 |
| KR100990524B1 (ko) | 2010-10-29 |
| EP1535913B1 (de) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1535913A4 (de) | NEUE QUATERNûRE AMMONIUMVERBINDUNGEN | |
| ATE555101T1 (de) | Neue benzothiazepin- und benzothiepinverbindungen | |
| ATE283266T1 (de) | 1,5-benzothiazepine und ihre verwendungs als hypolipidämika | |
| IS7170A (is) | Bensóþíasepín og bensóþíadíasepínafleiður með tálmavirkni gegn dausgarnargallsýruflutningi (ileal bile acid transport, IBAT) til að meðhöndla fitudreyra | |
| NO20040954L (no) | Benzotiazepinderivater for behandling av hyperlipidemi | |
| RU2002107975A (ru) | Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения | |
| DE60233239D1 (de) | Benzothiazepinderivate | |
| HUP0200793A3 (en) | An oral formulation for ileum administering comprising an inhibitor compound of the ileal bile acid transport | |
| IL187813A0 (en) | Pharmaceutical compositions of a neuroactive steroid and uses thereof | |
| WO2004016614A3 (en) | Pyrrolopyrazines as kinase inhibitors | |
| BRPI0412439A (pt) | compostos e composições compreendendo esteróis e/ou estanóis e inibidores de biossìntese de colesterol e uso dos mesmos no tratamento ou prevenção de uma variedade de doenças e condições | |
| IT1311922B1 (it) | Composti farmaceutici. | |
| BRPI0610312B8 (pt) | dispositivo de assistência à caminhada | |
| DE60022366D1 (de) | Kondensierte imidazolderivate und arzneimittel gegen diabetes mellitus | |
| DE60025616D1 (de) | Isoindolderivate | |
| TW200612920A (en) | Novel imidazolidine derivatives | |
| MXPA04003611A (es) | Piperidina- y piperazinacetaminas como inhibidores de la 17 beta-hidroxiesteroide deshidrogenasa tipo 3 para el tratamiento de enfermedades androgeno-dependientes. | |
| BR0213465A (pt) | Compostos de 4-imidazolin-2-ona | |
| WO2007025897A3 (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
| DK1750703T3 (da) | Fremgangsmåde til at reducere gastrointestinal toksitet forårsaget af indgivelsen af tegafur | |
| DK0988312T3 (da) | 17beta-allyloxy(thio)alkyl-androstanderivater til modulering af meiose | |
| ES2189080T3 (es) | Derivados de creatina para el asma. | |
| ITMI20021881A1 (it) | Composizioni farmaceutiche per il trattamento di infezioni da patogeni dell'apparato urinario. | |
| TW200730498A (en) | Compounds | |
| DK1219632T3 (da) | Steroider, deres fremstilling, farmaceutiske præparater deraf og anvendelser af forbindelserne |